26 related articles for article (PubMed ID: 1377543)
1. BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells.
Hausmann M; Leucht K; Ploner C; Kiessling S; Villunger A; Becker H; Hofmann C; Falk W; Krebs M; Kellermeier S; Fried M; Schölmerich J; Obermeier F; Rogler G
J Biol Chem; 2011 Jul; 286(30):26533-40. PubMed ID: 21673109
[TBL] [Abstract][Full Text] [Related]
2. Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma.
Riedl SE; Faissner A; Schlag P; Von Herbay A; Koretz K; Möller P
Gastroenterology; 1992 Aug; 103(2):400-6. PubMed ID: 1378802
[TBL] [Abstract][Full Text] [Related]
3. Specific expression of tenascin in human colonic neoplasms.
Sakai T; Kawakatsu H; Hirota N; Yokoyama T; Sakakura T; Saito M
Br J Cancer; 1993 May; 67(5):1058-64. PubMed ID: 7684238
[TBL] [Abstract][Full Text] [Related]
4. Tenascin expression in vitro and in vivo: comparison between epithelial and nonepithelial rat cell lines.
Sakai T; Kawakatsu H; Hirota N; Yokoyama T; Takoka T; Sakakura T; Saito M
Exp Cell Res; 1993 Jun; 206(2):244-54. PubMed ID: 7684694
[TBL] [Abstract][Full Text] [Related]
5. Human carcinoma cells synthesize and secrete tenascin in vitro.
Kawakatsu H; Shiurba R; Obara M; Hiraiwa H; Kusakabe M; Sakakura T
Jpn J Cancer Res; 1992 Oct; 83(10):1073-80. PubMed ID: 1280634
[TBL] [Abstract][Full Text] [Related]
6. Induction and altered distribution of tenascin in the basal lamina of colorectal adenomas and carcinomas.
Riedl S; Möller P; Faissner A; Schlag P
EXS; 1992; 61():277-81. PubMed ID: 1377543
[No Abstract] [Full Text] [Related]
7. Syndecan and tenascin: induction during early tooth morphogenesis and possible interactions.
Thesleff I; Vainio S; Salmivirta M; Jalkanen M
Cell Differ Dev; 1990 Dec; 32(3):383-9. PubMed ID: 1711918
[No Abstract] [Full Text] [Related]
8. Tenascin and other adhesion-modulating proteins in cancer.
Chiquet-Ehrismann R
Semin Cancer Biol; 1993 Oct; 4(5):301-10. PubMed ID: 7504958
[TBL] [Abstract][Full Text] [Related]
9. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications.
Koukoulis GK; Gould VE; Bhattacharyya A; Gould JE; Howeedy AA; Virtanen I
Hum Pathol; 1991 Jul; 22(7):636-43. PubMed ID: 1712747
[No Abstract] [Full Text] [Related]
10. Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions.
Erickson HP
Curr Opin Cell Biol; 1993 Oct; 5(5):869-76. PubMed ID: 7694605
[TBL] [Abstract][Full Text] [Related]
11. Can tenascin be redundant in cancer development?
Sakakura T; Kusakabe M
Perspect Dev Neurobiol; 1994; 2(1):111-16. PubMed ID: 7530137
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
